Leadership Overview
LabConnect has 4 executives leading key functions including strategy, technology, financial oversight, and fiscal management.
Focused on advancing global clinical research, LabConnect delivers innovative laboratory support services that bridge the gap between complex sample management and accurate data for biopharmaceutical clients worldwide.
Focused on advancing global clinical research, LabConnect delivers innovative laboratory support services that bridge the gap between complex sample management and accurate data for biopharmaceutical clients worldwide.
Leadership Roles at LabConnect
Richard Harris - Chief Executive Officer
Richard Harris, the Chief Executive Officer at LabConnect, directs the overarching corporate strategy and long-term vision for global central laboratory services. By aligning operational capabilities with the evolving needs of biopharmaceutical and CRO clients, the Chief Executive Officer ensures the organization maintains a competitive edge in complex clinical study support. Richard Harris architects high-level partnerships that expand market reach across major and emerging regions, facilitating seamless integration of preclinical through Phase IV development solutions. This leadership role involves constant evaluation of service delivery models to optimize sample management and data integrity. Through rigorous oversight of organizational performance, the Chief Executive Officer drives sustainable growth and innovation. By fostering a culture of excellence, the Chief Executive Officer empowers teams to deliver precise, client-inspired support for logistically demanding research projects, ultimately securing the company's position as a preeminent provider in the global life sciences sector.
Mitch Blumenfeld - Chief Financial Officer
Mitch Blumenfeld, the Chief Financial Officer at LabConnect, directs the financial strategy and capital allocation necessary to support the company's expansive laboratory and biorepository operations. Managing the fiscal health of the organization, the Chief Financial Officer ensures that resources align with the strategic goals of providing world-class support for biopharmaceutical clients. Mitch Blumenfeld architects comprehensive financial planning and analysis frameworks that facilitate sustainable investment in laboratory infrastructure and emerging market expansion. This leadership role involves rigorous oversight of budgetary performance and risk management to maintain long-term stability. By optimizing financial processes, the Chief Financial Officer supports the company's ability to deliver customized, high-quality project management services. Through disciplined fiscal governance, the Chief Financial Officer enables the organization to scale operations effectively, ensuring that the business remains well-positioned to meet the increasing demands of the global clinical development landscape while maintaining profitability and operational excellence.
)
Michael Lalor - Interim Chief Financial Officer & Vice President, Finance
Michael Lalor, the Interim Chief Financial Officer & Vice President, Finance at LabConnect, directs the day-to-day financial operations and accounting functions that underpin the company's clinical research support services. Overseeing the financial reporting and internal controls, the Interim Chief Financial Officer & Vice President, Finance ensures transparency and accuracy in all fiscal activities related to sample management and routine testing. Michael Lalor architects efficient financial workflows that support the company's diverse client base, ranging from small biotech firms to large CROs. This leadership role involves managing liquidity and cash flow to sustain the high-performance requirements of global clinical studies. By streamlining financial operations, the Interim Chief Financial Officer & Vice President, Finance provides the necessary stability for the organization to focus on its core mission of connecting samples to data. Through meticulous attention to financial detail, the Interim Chief Financial Officer & Vice President, Finance secures the operational foundation required for continued growth and service innovation.
Richard (Rich) LaBarca - Chief Technology Officer
Richard (Rich) LaBarca, the Chief Technology Officer at LabConnect, directs the development and implementation of state-of-the-art technology platforms essential for modern clinical trial management. Overseeing the digital infrastructure, the Chief Technology Officer ensures that sample tracking and data management systems remain robust, secure, and highly scalable for complex global studies. Richard (Rich) LaBarca architects innovative software solutions that connect high-quality laboratory samples to accurate, actionable data, directly supporting the company's mission to simplify drug development. This leadership role involves close collaboration with scientific teams to integrate advanced analytical tools into routine testing workflows. By prioritizing technological agility, the Chief Technology Officer enables the organization to adapt quickly to the unique requirements of diverse clinical programs. Through continuous investment in digital transformation, the Chief Technology Officer maintains the company's reputation for technical excellence and operational efficiency across all international research markets.
Explore Leadership Teams in Business Services
Brookhaven National Laboratory delivers discovery science and transformative technology to power and secure the nations future. Primarily supported by the U.S. Department of Energys (DOE) Office of Science, Brookhaven Lab is a multidisciplinary laboratory with seven Nobel Prize-winning discoveries, 37 R&D 100 Awards, and more than 70 years of pioneering research.
Company Leadership AS
SJ
Founded in 1991, Myriad Genetics is an American molecular diagnostic company specializing in discovering and delivering tests across major diseases. Myriad Genetics is located in Utah.
Company Leadership AS
MV
MG
Mistras Group, Inc. provides technology-enabled asset protection solutions in the United States, other Americas, Europe, and the Asia-Pacific. The company offers non-destructive testing services; inline inspection for pipelines; and plant condition management software. It also provides maintenance and light mechanical services, such as corrosion removal, mitigation and prevention, insulation installation and removal, electrical, heat tracing, industrial cleaning, pipefitting, and welding; engineering consulting services primarily for process equipment, technologies, and facilities; and utilizes scaffolding and rope access to access at-height and confined assets. In addition, the company offers certified divers for subsea inspection and maintenance; unmanned aerial, land-based, and subsea systems for inspection applications; online condition-monitoring solutions; quality assurance and quality control solutions for new and existing metal and alloy components, materials, and composites. Further, it builds monitoring systems, as well as provides inspection, maintenance, monitoring and data services; and Web-based solutions. Additionally, the company designs, manufactures, and sells acoustic emission sensors, instruments, and turnkey systems for monitoring and testing materials, pressure components, processes, and structures; and ultrasonic testing equipment. It serves oil and gas, aerospace and defense, fossil and nuclear power, power generation and transmission, civil infrastructure, manufacturing, industrial, public infrastructure, petrochemical, transportation, and other process industries, as well as infrastructure, research, and engineering industries. Mistras Group, Inc. was founded in 1978 and is headquartered in Princeton Junction, New Jersey.
Company Leadership NS
RF
EP
Commonwealth Fusion Systems is the world's largest and leading commercial fusion energy company, focused on developing high-temperature superconducting magnets to create smaller and more cost-effective tokamak fusion systems. The company is manufacturing the SPARC machine, which aims to be the first commercially-relevant net energy fusion device, paving the way for the ARC fusion power plant. CFS collaborates with a global ecosystem of suppliers and researchers to deliver clean, abundant energy and combat climate change. Their mission-driven team is dedicated to scientific integrity and the development of economically viable fusion energy solutions.
Company Leadership
AM
DT
Frequently Asked Questions Regarding LabConnect Top Executives and Leadership Team
